Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biomarin Pharmaceuticals
(NQ:
BMRN
)
92.57
-1.27 (-1.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biomarin Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Today 12:00 EDT
Via
Benzinga
Beyond The Numbers: 11 Analysts Discuss Biomarin Pharmaceutical Stock
August 20, 2024
Via
Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
August 20, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
August 14, 2024
While growth is established for BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), the stock's valuation remains reasonable.
Via
Chartmill
$1000 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
August 07, 2024
Via
Benzinga
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
August 06, 2024
BioMarin Pharmaceutical shifts focus to commercial operations for Roctavian in the U.S., Germany, and Italy. Projected cost reductions aim to achieve profitability by 2025. Strong Q2 performance driven...
Via
Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:BMRN.
July 24, 2024
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), a growth stock which is not overvalued.
Via
Chartmill
$1000 Invested In This Stock 20 Years Ago Would Be Worth $16,000 Today
July 16, 2024
Via
Benzinga
Peering Into Biomarin Pharmaceutical's Recent Short Interest
July 04, 2024
Via
Benzinga
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
August 06, 2024
Via
Benzinga
Biomarin Pharmaceutical Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results
August 06, 2024
Via
Benzinga
BMRN Stock Earnings: Biomarin Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
August 05, 2024
BMRN stock results show that Biomarin Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
A Glimpse Into The Expert Outlook On Biomarin Pharmaceutical Through 10 Analysts
July 22, 2024
Via
Benzinga
$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
July 18, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
June 27, 2024
Via
Benzinga
Looking Into Biomarin Pharmaceutical's Recent Short Interest
May 28, 2024
Via
Benzinga
NASDAQ:BMRN is not too expensive for the growth it is showing.
May 21, 2024
Looking for growth without the hefty price tag? Consider BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN).
Via
Chartmill
Investors should take note of NASDAQ:BMRN, a growth stock that remains attractively priced.
July 02, 2024
Investors should take note ofBIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), a growth stock that remains attractively priced.
Via
Chartmill
For those who appreciate growth without the sticker shock, NASDAQ:BMRN is worth considering.
June 11, 2024
While growth is established for BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN), the stock's valuation remains reasonable.
Via
Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
June 07, 2024
KKR and GoDaddy also will join before the open on June 24.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
June 05, 2024
Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.
Via
InvestorPlace
Analyst Ratings For Biomarin Pharmaceutical
May 14, 2024
Via
Benzinga
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
May 09, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via
Benzinga
BridgeBio Stock Makes A Bullish Move On Dwarfism Treatment Results
June 04, 2024
BridgeBio stock rallies on upbeat study results of a drug for a genetic disease that affects the limbs and spine.
Via
Investor's Business Daily
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
May 19, 2024
Last week, these 10 large-cap stocks had the worst performance. NICE, PBR, FIX, LI, MLM, VMC, BMRN, EDU, GFI, MUFG all saw significant decreases.
Via
Benzinga
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
May 18, 2024
Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
May 17, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in May 2024
May 09, 2024
If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.